Human and Helicobacter pylori coevolution shapes the risk of gastric disease
- PMID: 24474772
- PMCID: PMC3910595
- DOI: 10.1073/pnas.1318093111
Human and Helicobacter pylori coevolution shapes the risk of gastric disease
Abstract
Helicobacter pylori is the principal cause of gastric cancer, the second leading cause of cancer mortality worldwide. However, H. pylori prevalence generally does not predict cancer incidence. To determine whether coevolution between host and pathogen influences disease risk, we examined the association between the severity of gastric lesions and patterns of genomic variation in matched human and H. pylori samples. Patients were recruited from two geographically distinct Colombian populations with significantly different incidences of gastric cancer, but virtually identical prevalence of H. pylori infection. All H. pylori isolates contained the genetic signatures of multiple ancestries, with an ancestral African cluster predominating in a low-risk, coastal population and a European cluster in a high-risk, mountain population. The human ancestry of the biopsied individuals also varied with geography, with mostly African ancestry in the coastal region (58%), and mostly Amerindian ancestry in the mountain region (67%). The interaction between the host and pathogen ancestries completely accounted for the difference in the severity of gastric lesions in the two regions of Colombia. In particular, African H. pylori ancestry was relatively benign in humans of African ancestry but was deleterious in individuals with substantial Amerindian ancestry. Thus, coevolution likely modulated disease risk, and the disruption of coevolved human and H. pylori genomes can explain the high incidence of gastric disease in the mountain population.
Keywords: Latin America; admixture; histopathology; inflammation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Peek RM, Jr, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2(1):28–37. - PubMed
-
- Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. - PubMed
-
- Chiba T, Seno H, Marusawa H, Wakatsuki Y, Okazaki K. Host factors are important in determining clinical outcomes of Helicobacter pylori infection. J Gastroenterol. 2006;41(1):1–9. - PubMed
-
- Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2004;9(Suppl 1):1–6. - PubMed
Publication types
MeSH terms
Grants and funding
- P30 DK058404/DK/NIDDK NIH HHS/United States
- R01 AT004821/AT/NCCIH NIH HHS/United States
- P01 CA116087/CA/NCI NIH HHS/United States
- R01 AI039657/AI/NIAID NIH HHS/United States
- UL1 RR024975/RR/NCRR NIH HHS/United States
- R01 DK058587/DK/NIDDK NIH HHS/United States
- R01 AI068009/AI/NIAID NIH HHS/United States
- UL1 RR024975-01/RR/NCRR NIH HHS/United States
- P20 GM103534/GM/NIGMS NIH HHS/United States
- UL1 TR000445/TR/NCATS NIH HHS/United States
- R01 DK053620/DK/NIDDK NIH HHS/United States
- P01 CA028842/CA/NCI NIH HHS/United States
- R01 CA077955/CA/NCI NIH HHS/United States
- T32 AI007474/AI/NIAID NIH HHS/United States
- T32 GM080178/GM/NIGMS NIH HHS/United States
- P01 CA28842/CA/NCI NIH HHS/United States
- 2 UL2 TR000445/TR/NCATS NIH HHS/United States
- R01 CA77955/CA/NCI NIH HHS/United States
- T32 GM007347/GM/NIGMS NIH HHS/United States
- I01 BX000627/BX/BLRD VA/United States
- I01 BX001453/BX/BLRD VA/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
